All Press Releases for December 03, 2019

Jonathan L. Sessler, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who

Dr. Sessler has been endorsed by Marquis Who's Who as a leader in the field of chemistry

Jonathan L. Sessler, PhD, is currently the W. T. Doherty-Welch chair and a professor in chemistry at the University of Texas at Austin.

    AUSTIN, TX, December 03, 2019 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Jonathan L. Sessler, PhD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Sessler celebrates many years' experience in his profession, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

With more than 30 years of experience to his credit, Jonathan L. Sessler, PhD, is currently the W. T. Doherty-Welch chair and a professor in chemistry at the University of Texas at Austin, a position he has held since 2001. Prior to this appointment, he worked at the aforementioned university as a professor between 1992 and 2001. Previously, he served at the University of Texas at Austin as an associate professor from 1989 until 1992. Dr. Sessler began his career at the University of Texas at Austin as an assistant professor from 1984 to 1989.

Before embarking on his professional path, Dr. Sessler pursued an education at the University of California Berkeley, earning a Bachelor of Sciences in 1977. He concluded his studies at Stanford University in 1982, graduating with a Doctor of Philosophy. In the course of his studies, Dr. Sessler was motivated by a number of mentors, including Richard A. Miller, MD, and Professors Alex Pines, James P. Collman, Jean Marie Lehn, and Iwao Tabusi.

Beyond his responsibilities within academia, Dr. Sessler has participated in numerous endeavors outside of his professional circles. The co-founder of Cible, Inc. since 2016, he has held a visiting professorship and Center Directorate at Shanghai University from 2015. A standing member of the Synthetic and Biological Chemistry A study section for the National Institutes of Health from 2005 to 2009 and from 2019 to 2023, he formerly held the role of the co-founder of Anionics, Inc. from 2003 to 2012 and Pharmacyclics, Inc. from 1991 to 2011, for which he was additionally active as a consultant. A contributing author for over 760 published papers, Dr. Sessler found success with his editorial work as well, serving as an associate editor for "ChemComm" from 2005 to 2019 and an editor of "Supramolecular Chemistry" from 2000 to 2010.

In addition to his primary vocation, Dr. Sessler remains affiliated with various organizations unrelated to his areas of expertise. Since 2003, he has maintained his involvement as a member of Temple Beth Shalom in Austin. He was also associated with the American Chemical Society and the Royal Society of Chemistry. Moreover, Dr. Sessler has been a member of the board of directors for the Austin Opera since 2018 and the Austin Symphony since 2016.

In light of his exceptional undertakings, Dr. Sessler has accrued several accolades throughout his impressive career. A fellow of the American Association for the Advancement of Science in 1999 and the Alfred P. Sloan Foundation in 1989, his innovation was recognized with 75 patents for texaphyrin, sapphyrin, calixpyrrole and many related inventions. Notably, he was presented with a Dreyfus Teacher Scholar Award in 1988, a Cope Scholar Award from the American Chemical Society in 1991, a Senior Scientist Award from the Alexander von Humboldt Foundation in 1992, an Izatt-Christiansen Award in 2001, a Senior Scientist Award from the Japan Society for the Promotion of Science in 1992 and 2004, the C. David Gutsche Award in 2019, and The University of Texas Co-op Career Research Award in 2019. Likewise, Dr. Sessler was selected for inclusion in multiple editions of Who's Who in America and Who's Who in the South and Southwest.

Growing up in a family of academics, Dr. Sessler was inspired by his father, a physicist, and his mother, the first female to earn an advanced degree in physics from Columbia University in the early 1950s. A three-time cancer survivor, he proudly recalls inventing the class of molecules that have come to be known as expanded porphyrins and which he believes represented the start of a new field in academics. Looking toward the future, Dr. Sessler hopes to develop at least one more potential cancer drug. He is working with Oncotex, a newly founded company, to advance this latter goal.

In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Dr. Sessler has been featured on the Albert Nelson Marquis Lifetime Achievement website. Please visit for more information about this honor.

About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Berkeley Heights, NJ
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: